Ac-225-PSMA-617
225Ac-PSMA-617 is the next generation of prostate cancer treatment following [...]
Th-227-Epratuzumab (Th-227-BAY1862864)
227Th-Epratuzumab (227Th-BAY1862864 is a CD-22 thorium conjugate targeting relapsed or [...]
Ra-224-Radium Chloride (224-SpondylAT®)
224Ra-Radium Chloride was used for a long time between the [...]
Ac-225-RYZ101
225Ac-RYZ101 (225Ac-DOTATATE) is the alpha-labeled analogue of 90Y- and 177Lu-DOTATATE. [...]
Ac-225-DOTATOC
225Ac-DOTATOC is one alpha-labeled analogue of 90Y- and 177Lu-DOTATOC [...]
Ac-225-DOTAZOL
225Ac-DOTAZOL is a DOTA Zoledronic acid derivative suitable for alphatherapy [...]
Th-227-Pelgifatamab
227Th-Pelgifatamab(227Th-PSMA-TTC, 227Th-BAY2315497) is a Thorium-227 labelled PSMA-targeted full IgG antibody [...]
Ra-224-RadSpherin
224Ra-RadSpherin is a suspension of Radium-224 in degradable calcium carbonate [...]
Th-227-Anetumab corixetan
227Th-Anetumab corixetan (227Th-BAY2287411) is a mesothelin targeted thorium conjugate (MSLN-TTC) [...]
Ac-225-Rosopatamab
225Ac-Rosopatamab (225Ac-CONV-01-α) is an alpha-radiolabeled monoclonal antibody targeting PSMA [...]